Neuronetics Showcases NeuroStar TMS at AACAP Annual Meeting
Neuronetics Presents NeuroStar TMS at AACAP Annual Meeting
MALVERN, Pa. - Neuronetics, Inc. (NASDAQ: STIM), a leading medical technology company, has announced its participation in the American Academy of Child and Adolescent Psychiatry (AACAP) Annual Meeting. This event commenced today and will run until October 19th. Neuronetics is particularly excited to showcase its innovative NeuroStar Transcranial Magnetic Stimulation (TMS) System, along with an important oral presentation by Dr. Paul E. Croarkin scheduled for October 16th.
Highlighting Innovative Treatments for Mental Health
The focus of the upcoming presentation will center on an extensive study involving adolescents and young adults suffering from major depressive disorder (MDD) treated with TMS. The preliminary data reveal remarkable results, showing a 78% response rate and a 48% remission rate among the adolescent patients analyzed. Notably, the average improvement exceeded 10 points in depression symptoms as measured by the Patient Health Questionnaire-9 (PHQ-9).
Significance of NeuroStar in Adolescent Treatment
Cory Anderson, the Senior Vice President of Research & Development and Clinical at Neuronetics, emphasized the crucial role that the NeuroStar TMS System plays for younger patients who have limited options for approved treatments. The NeuroStar system is clinically validated and FDA-cleared for treating adolescents aged 15 and up as an initial adjunct treatment for MDD.
Positive Clinical Outcomes Reinforced
Dr. Melissa Fickey, an AACAP member and board-certified psychiatrist, reinforced the favorable clinical outcomes that have been observed since the FDA clearance of NeuroStar for adolescent use earlier this year. This approval has been a significant milestone for the company.
The Future of NeuroStar Therapy
Neuronetics is dedicated to addressing mental health concerns with the same seriousness as physical health, striving to reshape how patients and healthcare providers view treatment expectations. The NeuroStar Advanced Therapy is non-experimental, noninvasive, and represents a pivotal advancement in mental health care options. Besides treating adolescents, the NeuroStar TMS System has also received FDA clearance for adults suffering from obsessive-compulsive disorder.
Interactive Demonstration and Further Engagement
During the AACAP meeting, Neuronetics will showcase the NeuroStar TMS System at booth #416. This hands-on demonstration aims to educate attendees about the benefits of TMS Therapy. For interested individuals seeking more information about NeuroStar TMS Therapy, Neuronetics encourages them to visit the company’s official website for comprehensive details.
Current Market Position and Financial Overview
Recently, Neuronetics reported a second-quarter revenue of $16.5 million, which unfortunately did not meet previous estimates. This discrepancy is attributed to changing purchasing behaviors likely influenced by industry developments, including the Change Health cyberattack. Despite these hurdles, Neuronetics witnessed an impressive 18% increase in the utilization of local consumables, indicating a robust demand for their groundbreaking treatments.
Strategic Mergers and Future Profitability
The company is also on the verge of a merger with Greenbrook TMS, which is expected to create significant revenue and cost synergies, ultimately driving Neuronetics towards consistent profitability post-2025. This merger is anticipated to enhance operational efficiencies while expanding the therapeutic reach and brand recognition of NeuroStar TMS therapy across broader healthcare networks.
Marketing and Community Engagement Efforts
In an ongoing effort to raise awareness of the NeuroStar therapy, Neuronetics is investing in its Better Me Guarantee Program alongside launching a television advertising campaign located in Tampa Bay, Florida. The company remains optimistic, having reaffirmed its revenue projections for 2024, estimating between $78 million and $80 million. This outlook reflects their ongoing strategic initiatives aimed at overcoming present challenges with a focus on achieving positive cash flow by 2025.
Frequently Asked Questions
What is NeuroStar TMS?
NeuroStar TMS is an FDA-cleared noninvasive treatment targeting major depressive disorder and other mental health conditions using Transcranial Magnetic Stimulation.
When was the NeuroStar TMS System FDA cleared for adolescent use?
The NeuroStar TMS System received FDA clearance for adolescents with major depressive disorder earlier this year.
What are the presentation highlights at AACAP?
The presentation will showcase groundbreaking data on TMS treatment outcomes among adolescents and young adults with major depressive disorder.
How is Neuronetics preparing for future profitability?
Neuronetics is pursuing a merger with Greenbrook TMS, aiming for enhanced operational efficiencies and revenue growth to achieve profitability by 2025.
What other treatments does NeuroStar provide?
In addition to treating adolescents with MDD, NeuroStar TMS is also FDA-cleared for adults with obsessive-compulsive disorder.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- RiverMeadow Enhances Migration Options with AWS Integration
- Woodpecker International's Renewed Bid for Hong Kong Listing
- Exploring Mulligan Asset Securitization II LLC Series 2024-1 Notes
- Innovative Trailer Rental Software Revolutionizes Reservations
- Pepe's Price Surge: What You Need to Know Today
- Candidates Urged to Commit to Children's Internet Safety Pledge
- Freddy's Frozen Custard Expands Into NHL with New Location
- Highwoods Properties Celebrates Significant Stock Milestone
- Eli Lilly's Mirikizumab Outperforms Johnson & Johnson's Treatment
- NUBURU Cancels Special Meeting: Implications for Investors
Recent Articles
- Molex's Latest Report: The Shift to Advanced 48V Systems
- Stellantis Broadens Employee Stock Ownership to Boost Engagement
- Air Products Plans Fourth Quarter Earnings Teleconference
- Quest Diagnostics Enhances Lab Services with New Acquisition
- Wells Fargo Downgrades Amer Sports Rating Amid Strong Growth
- Essential Insights on Improving Workplace Culture
- Alkermes Focuses on Orexin Strategy with Positive Analyst Outlook
- Tesla's Growing Position Amid Mixed Analyst Ratings and Events
- Exploring the Rapid Growth of the AI Camera Market
- beaconsmind Group Elevates Connectivity in Shopping Centers
- B. Riley Financial's Strategic Asset Sale Enhances Stability
- Discover Sysco's Innovative Fall 2024 Solutions Now
- Elliott Investment Management Calls for Special Meeting with LUV
- Boeing Navigates Job Cuts Amidst Significant Jet Delivery Delays
- First Watch Restaurant Group's Resilience After Hurricane Milton Impact
- Amer Sports Stock Receives Equal Weight Rating Amidst Growth
- Crane NXT Welcomes Dr. Aleta Richards as New President
- Innovative Electron Microscope Enhances Advanced Material Research
- Revolutionizing Healthcare: Oracle Health's New Data Exchange
- LOTTE HOTELS & RESORTS Enhances Guest Experience with Sabre
- Dun & Bradstreet Empowers Businesses with AI Data Insights
- Unisys Prepares for Upcoming Third-Quarter Financial Review
- Aprea Therapeutics to Showcase Innovation at Upcoming Summit
- Facteus Unveils Comprehensive Data Solutions for Consumers
- Germfree Expands Facility Solutions with Arcoplast Acquisition
- Nexalin Technology Welcomes Carolyn Shelton to Executive Team
- Revolutionizing Power Solutions: Navitas GaNSlim™ IC Details
- Strategic Leadership Shift at Arch Capital Enhances Focus on Growth
- Lundbeck's Strategic Move to Acquire Longboard Pharmaceuticals
- Innovative Eyewear Unveils Pioneering AI-Driven Fashion Show
- Airgain to Discuss Q3 2024 Results in Upcoming Earnings Call
- Verb Technology Company Outlines Strategic Vision for Growth
- Federated Hermes Opens Tender Offer for Shareholders Benefits
- iPower Enhances U.S. Marketplace Access through AliExpress
- Trump Media Unveils Truth+ Streaming Service for Everyone
- RXO Adjusts Earnings Call Timing to Enhance Accessibility
- Innovative Presentation at AACAP 2024 Showcases TMS Benefits
- Kintara Therapeutics Sets Record Date for Exciting CVR Issuance
- Stellantis Expands Global Employee Share Plan for Workforce Growth
- Savor the New Big Dip: Burger King's Flavorful Collaboration
- Turtle Beach Expands Gaming Accessories Horizons in Latin America
- SuRo Capital: Investing in Tomorrow's Innovative Technologies
- OneSpan Unveils VISION FX for Enhanced Digital Banking Security
- SOFA.org Introduces SOFA Points for Enhanced User Rewards
- AM Best Engages Insurance Professionals at Key Conference
- Discovering the Legacy of the Devine Family in New Book
- Maximizing Dividend Income from Goldman Sachs Stocks
- Lightwave Logic's Technological Innovations Shine at European Conference
- Celebrating a Decade of Innovation at O&C Investment Alliance
- Portugal Reaches New Heights with Over a Million Foreign Residents